- Exact Sciences schedules second quarter 2024 earnings call
- Exact Sciences to Participate in June Investor Conferences
- Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
- Exact Sciences Earns 2024 Great Place To Work® Certification™
- Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy
- Exact Sciences Announces First-Quarter 2024 Results
- Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
- Exact Sciences to Participate in May Investor Conference
More ▼
Key statistics
On Monday, Exact Sciences Corp (EXAS:NAQ) closed at 48.17, 18.56% above the 52 week low of 40.62 set on Jun 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 47.44 |
---|---|
High | 48.47 |
Low | 47.24 |
Bid | 46.10 |
Offer | 48.50 |
Previous close | 46.81 |
Average volume | 2.65m |
---|---|
Shares outstanding | 184.53m |
Free float | 182.72m |
P/E (TTM) | -- |
Market cap | 9.11bn USD |
EPS (TTM) | -1.32 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 21:00 BST.
More ▼